Research Grants to Support Etiologic and Effectiveness Research on Driving While Polysubstance Impaired
On December 12, 2018, the CDC released RFA-CE-19-004, Etiologic and Effectiveness Research to Address Polysubstance Impaired Driving. CDC intends to commit up to $1,400,000 in Fiscal Year 2019 to support four awards. The maximum award amount will be $350,000 per award for the first 12 month budget period. The purpose of this funding is to support etiologic and effectiveness research on driving while polysubstance impaired. Polysubstance impaired driving means driving while impaired by alcohol plus at least one other drug, such as marijuana or opioids. Specifically, the agency is soliciting research to address one of two priorities:
In 2016, one-third of all traffic-related deaths were in crashes that involved an alcohol-impaired driver, and more than 1 million drivers were arrested for impaired driving (alcohol or narcotics). Research on impaired driving due to marijuana, prescription or illicit opioids, and polysubstance use is currently limited.
- Priority #1: Identify risk and protective factors associated with polysubstance impaired driving and its associated deaths and injuries. Projects funded under Research Priority #1 of this notice of funding opportunity (NOFO) will investigate the risk and protective factors and crash characteristics associated with impaired driving involving alcohol plus other drugs that result in deaths and injuries.
- Priority #2: Identify effective interventions to prevent polysubstance impaired driving and its associated deaths and injuries. Projects funded under Research Priority #2 of this NOFO will evaluate the effectiveness of intervention programs for reducing deaths and injuries associated with polysubstance impaired driving.
The goal of this research funding is to inform our understanding of 1) the characteristics and protective and risk factors associated with polysubstance impaired driving, and 2) interventions most effective at preventing polysubstance impaired driving. Increasing our understanding of polysubstance impaired driving could inform prevention efforts at both the federal and state levels. State departments of health and transportation could use the results of this research to prioritize safety interventions, which would then lead to reductions in deaths and injuries associated with polysubstance impaired driving.
The Notice of Funding Opportunity can be found at www.grants.gov by searching for RFA-CE-19-004.
Letter of intent due: January 25, 2019
Applications due: March 15, 2019
Post a Comment